Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 29, 2025, RAPT Therapeutics (RAPT) has a market cap of $0.12 billion USD. According to our data, RAPT Therapeutics is ranked No.7463 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 29, 2025 | $0.12 B |
-41.70%
|
| Dec 31, 2024 | $0.21 B |
-93.64%
|
| Dec 29, 2023 | $3.28 B |
25.51%
|
| Dec 30, 2022 | $2.61 B |
-46.09%
|
| Dec 31, 2021 | $4.85 B |
85.97%
|
| Dec 31, 2020 | $2.61 B |
-28.47%
|
| Dec 31, 2019 | $3.64 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
USA
|
 Incyte
INCY
|
$11.52 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$66.78 B |
1.110 B
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$12.08 B |
0.000 M
|
USA
|
 Alkermes
ALKS
|
$4.61 B |
7.418 M
|
Ireland
|
 Blueprint Medicines
BPMC
|
$5.66 B |
-0.058 B
|
USA
|
 Exelixis
EXEL
|
$10.57 B |
-0.028 B
|
USA
|
 MacroGenics
MGNX
|
$0.11 B |
4.841 M
|
USA
|
 Nektar Therapeutics
NKTR
|
$0.14 B |
0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.17 B |
5.897 M
|
USA
|
 TG Therapeutics
TGTX
|
$6.58 B |
-0.024 B
|
USA
|
 Xencor
XNCR
|
$0.74 B |
-9.961 M
|
USA
|
| Market Cap | = | RAPT Stock Price | * | RAPT Shares Outstanding |
| = | $0.92 | * | 0.13 B | |
| = | $0.12 B |